Statements (54)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:DJ
|
| gptkbp:associated_with |
reinfections
|
| gptkbp:characteristics |
high transmissibility
|
| gptkbp:clinical_trial |
ongoing for updated vaccines
|
| gptkbp:community |
focused on understanding its behavior
|
| gptkbp:community_impact |
increased cases reported
|
| gptkbp:data_usage |
higher than previous variants
|
| gptkbp:descendant |
B.1.1.529
descendant of Omicron |
| gptkbp:discovered_by |
gptkb:2021
|
| gptkbp:distributes |
rapidly spread worldwide
|
| gptkbp:economic_impact |
widespread disruptions observed
|
| gptkbp:formation_date |
November 26, 2021
|
| gptkbp:genetic_diversity |
multiple spike protein mutations
required for identification |
| gptkbp:healthcare |
increased testing and vaccination efforts
strain on resources significant worldwide emphasize vaccination and boosters mask mandates reintroduced in some areas |
| https://www.w3.org/2000/01/rdf-schema#label |
Omicron BA.1
|
| gptkbp:is_monitored_by |
critical for public health
critical for controlling outbreaks |
| gptkbp:is_recognized_by |
gptkb:South_Africa
|
| gptkbp:is_vulnerable_to |
reduced against infection
|
| gptkbp:origin |
continuing to evolve
|
| gptkbp:public_awareness |
increased media coverage
|
| gptkbp:receives_funding_from |
increased for COVID-19 variants
|
| gptkbp:recommendation |
updated by health authorities
|
| gptkbp:related_model |
part of the Omicron variant family
|
| gptkbp:research_focus |
vaccine adaptations
|
| gptkbp:responds_to |
requires international cooperation
adaptations in treatment protocols |
| gptkbp:risk_factor |
under investigation
|
| gptkbp:scientific_classification |
November 2021
Variant of Concern |
| gptkbp:seating_capacity |
travel restrictions imposed by many countries
|
| gptkbp:side_effect |
increased hospitalizations
|
| gptkbp:social_responsibility |
conducted to understand spread
|
| gptkbp:supports |
studies ongoing
|
| gptkbp:symptoms |
similar to other COVID-19 variants
|
| gptkbp:track |
ongoing genomic surveillance
|
| gptkbp:treatment |
reduced effectiveness of some monoclonal antibodies
|
| gptkbp:variant |
ongoing globally
evolving rapidly developed by health organizations enhanced globally compared to Delta variant for future pandemic preparedness. includes immune escape properties linked to increased mutations undergoes mutations frequently |
| gptkbp:bfsParent |
gptkb:TS-19
|
| gptkbp:bfsLayer |
5
|